Lactiplantibacillus Plantarum

OTHER NAME(S): L. plantarum, Lactobacillus plantarum, Lactiplantibacillus plantarum

Overview

Lactiplantibacillus plantarum (L. plantarum) is a probiotic bacteria available over the counter as a supplement and in some fermented foods. It is commonly used for weight loss and to improve gut and mouth health, but its benefits are not well defined. Common side effects include gas and an upset stomach. Serious side effects are rare, but they may include infections in some people who are at high risk of infections. Before using L. plantarum, make sure to tell your health care provider about any health conditions you have or medicines you are taking.

References
  1. BiomeCore Probiotic Capsules (Blue Heron Pharmaceuticals) Supplement Facts Label, December 2025.
  2. Floresta Probiotic Capsules (Blue Heron Pharmaceuticals) Supplement Facts Label, August 2025.
  3. International Journal of Molecular Sciences: “The role of Lactobacillus plantarum in reducing obesity and inflammation: A meta-analysis.”
  4. National Center for Complementary and Integrative Health: “5 Things To Know About Probiotics,” “Probiotics: Usefulness and Safety.”
  5. National Institutes of Health Office of Dietary Supplements: “Probiotics Fact Sheet for Consumers,” “Probiotics Fact Sheet for Health Professionals.”
  6. Nature Reviews Gastroenterology & Hepatology: “The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on fermented foods.”
  7. NPJ Aging: “Probiotic Lactiplantibacillus plantarum OL3246 supports healthy aging by enhancing quality of life, reducing inflammation, and modulating gut microbiota: a pilot study.”
  8. NuGut Capsules (Trivia Pharmaceuticals) Supplement Facts Label, March 2025.
  9. Nutrients: “Strain-specific therapeutic potential of Lactiplantibacillus plantarum: a systematic scoping review.”
  10. Probiotics and Antimicrobial Proteins: “The health benefits of probiotic Lactiplantibacillus plantarum: a systematic review and meta‑analysis.”
  11. U.S. FDA: “FDA Raises Concerns About Probiotic Products Sold for Use in Hospitalized Preterm Infants.”